Cargando…

The Barriers and Facilitators of Different Stakeholders When Deprescribing Benzodiazepine Receptor Agonists in Older Patients—A Systematic Review

Treatment of older patients with benzodiazepines and Z-drugs (BZRA) is associated with an increased risk of side effects. However, this treatment is still used among these patients. Deprescribing can be a tool to reduce inappropriate medication. This review aims to identify and compare barriers and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rasmussen, Anja Fog, Poulsen, Sarah Sonne, Oldenburg, Lykke Ida Kaas, Vermehren, Charlotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073998/ https://www.ncbi.nlm.nih.gov/pubmed/33923956 http://dx.doi.org/10.3390/metabo11040254

Ejemplares similares

Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing
por: Kaas Oldenburg, Lykke I., et al.
Publicado: (2022)

Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: A qualitative study of stakeholder groups
por: Evrard, Perrine, et al.
Publicado: (2023)

Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework
por: Evrard, Perrine, et al.
Publicado: (2022)

Exploration of Barriers and Facilitators for Deprescribing Opioids and Benzodiazepines to Reduce Older Adult Falls
por: Roberts, Ellen, et al.
Publicado: (2020)

The Risk of Drug-Drug Interactions with Paracetamol in a Population of Hospitalized Geriatric Patients
por: Kaas Oldenburg, Lykke Ida, et al.
Publicado: (2020)

Current practice in benzodiazepine receptor agonists deprescribing on acute geriatric wards: a cohort study
por: Sibille, François-Xavier, et al.
Publicado: (2022)

The role of pharmacists in deprescribing benzodiazepines: A scoping review
por: Ashkanani, Fatemah Zakariya, et al.
Publicado: (2023)

Deprescribing benzodiazepines among hospitalised older adults: quality improvement initiative
por: Carr, Frances, et al.
Publicado: (2019)

Implementation of an Opioid and Benzodiazepine Deprescribing Program for Older Adults in an Outpatient Setting
por: Armistead, Lori, et al.
Publicado: (2020)

Primary-Care Prescribers’ Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults
por: Niznik, Joshua D., et al.
Publicado: (2022)

Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
por: Pollmann, André S., et al.
Publicado: (2015)

A Need for Benzodiazepine Deprescribing in the COVID-19 Pandemic: A Cohort Study
por: Bužančić, Iva, et al.
Publicado: (2022)

Deprescribing Strategies for Opioids and Benzodiazepines with Emphasis on Concurrent Use: A Scoping Review
por: Wang, Yanning, et al.
Publicado: (2023)

Exploration of Symptom Scale as an Outcome for Deprescribing: A Medication Review Study in Nursing Homes
por: Dalin, Dagmar Abelone, et al.
Publicado: (2022)

Barriers and facilitators to deprescribing in primary care: a systematic review
por: Doherty, Alison Jayne, et al.
Publicado: (2020)

Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review
por: Brunner, Laureline, et al.
Publicado: (2022)

Maternal Characteristics of Women Exposed to Hypnotic Benzodiazepine Receptor Agonist during Pregnancy
por: Askaa, Bjarke, et al.
Publicado: (2014)

Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study
por: Keller, Michelle S, et al.
Publicado: (2023)

Emotional barriers and facilitators of deprescribing for older adults with cancer and polypharmacy: a qualitative study
por: Ramsdale, Erika, et al.
Publicado: (2023)

The impact of in hospital patient-education intervention on older people’s attitudes and intention to have their benzodiazepines deprescribed: a feasibility study
por: Gnjidic, Danijela, et al.
Publicado: (2019)

Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)

Supporting medication discontinuation: provider preferences for interventions to facilitate deprescribing
por: Linsky, Amy, et al.
Publicado: (2017)

Protocol for DEprescribing and Care to reduce Antipsychotics in Dementia (DECADE)–A hybrid effectiveness-implementation pilot study
por: Benthien, Kirstine Skov, et al.
Publicado: (2023)

Supporting deprescribing in long-term care: An approach using stakeholder engagement, behavioural science and implementation planning
por: McCarthy, Lisa M., et al.
Publicado: (2022)

Identification of behaviour change techniques in deprescribing interventions: a systematic review and meta‐analysis
por: Hansen, Christina R., et al.
Publicado: (2018)

Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial
por: Mortsiefer, Achim, et al.
Publicado: (2023)

Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping review
por: Oktora, M. P., et al.
Publicado: (2020)

Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
por: Le Bosquet, Katherine, et al.
Publicado: (2019)

Deprescribing in older people
por: Liacos, Michelle, et al.
Publicado: (2020)

DEPRESCRIBING IN ASSISTED LIVING
por: Zarowitz, Barbara, et al.
Publicado: (2022)

Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing
por: Farrell, Barbara, et al.
Publicado: (2016)

Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2013)

Differences in Benzodiazepine Receptor Agonist Use in Rural and Urban Older Adults
por: Mattos, Meghan K., et al.
Publicado: (2016)

Benzodiazepines II: Waking Up on Sedatives: Providing Optimal Care When Inheriting Benzodiazepine Prescriptions in Transfer Patients
por: Guina, Jeffrey, et al.
Publicado: (2018)

Provider anticipation and experience of patient reaction when deprescribing guideline discordant inhaled corticosteroids
por: Parikh, Toral J., et al.
Publicado: (2020)

Facilitators and Barriers Influencing Antipsychotic Medication Prescribing and Deprescribing Practices in Critically Ill Adult Patients: a Qualitative Study
por: Jaworska, Natalia, et al.
Publicado: (2023)

A systematic review of the barriers to and facilitators of the use of evidence by philanthropists when determining which charities (including health charities or programmes) to fund
por: Greenhalgh, Caroline, et al.
Publicado: (2020)

‘I just thought that it was such an impossible thing’: A qualitative study of barriers and facilitators to discontinuing long‐term use of benzodiazepine receptor agonists using the Theoretical Domains Framework
por: Lynch, Tom, et al.
Publicado: (2021)

Perceptions of Hospital-at-Home Among Stakeholders: a Meta-synthesis
por: Chua, Crystal Min Siu, et al.
Publicado: (2021)

Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe
por: Shrestha, Shakti, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6qebrbpi9htg16spe0rjg08cqb